<?xml version="1.0" encoding="UTF-8"?>

<document id="DDI-DrugBank.d571"> 
   <sentence id="DDI-DrugBank.d571.s0" text="No formal drug interaction studies have been conducted with VELCADE." new_text="No@@formal@@drug@@interaction@@studies@@have@@been@@conducted@@with@@VELCADE@@.@@"> 
      <entity id="DDI-DrugBank.d571.s0.e0" charOffset="60-66" type="brand" text="VELCADE" position="9"/> 
   </sentence>  
   <sentence id="DDI-DrugBank.d571.s1" text="In vitro studies with human liver microsomes indicate that bortezomib is primarily a substrate for cytochrome P450 3A4, 2C19, and 1A2." new_text="In@@vitro@@studies@@with@@human@@liver@@microsomes@@indicate@@that@@bortezomib@@is@@primarily@@a@@substrate@@for@@cytochrome@@P450@@3A4@@,@@2C19@@,@@and@@1A2@@.@@"> 
      <entity id="DDI-DrugBank.d571.s1.e0" charOffset="59-68" type="drug" text="bortezomib" position="9"/> 
   </sentence>  
   <sentence id="DDI-DrugBank.d571.s2" text="Patients who are concomitantly receiving VELCADE and drugs that are inhibitors or inducers of cytochrome P450 3A4 should be closely monitored for either toxicities or reduced efficacy ." new_text="Patients@@who@@are@@concomitantly@@receiving@@VELCADE@@and@@drugs@@that@@are@@inhibitors@@or@@inducers@@of@@cytochrome@@P450@@3A4@@should@@be@@closely@@monitored@@for@@either@@toxicities@@or@@reduced@@efficacy@@.@@"> 
      <entity id="DDI-DrugBank.d571.s2.e0" charOffset="41-47" type="brand" text="VELCADE" position="5"/> 
   </sentence>  
   <sentence id="DDI-DrugBank.d571.s3" text="During clinical trials, hypoglycemia and hyperglycemia were reported in diabetic patients receiving oral hypoglycemics." new_text="During@@clinical@@trials@@,@@hypoglycemia@@and@@hyperglycemia@@were@@reported@@in@@diabetic@@patients@@receiving@@oral@@hypoglycemics@@.@@"> 
      <entity id="DDI-DrugBank.d571.s3.e0" charOffset="105-117" type="group" text="hypoglycemics" position="14"/> 
   </sentence>  
   <sentence id="DDI-DrugBank.d571.s4" text="Patients on oral antidiabetic agents receiving VELCADE treatment may require close monitoring of their blood glucose levels and adjustment of the dose of their antidiabetic medication." new_text="Patients@@on@@oral@@antidiabetic agents@@receiving@@VELCADE@@treatment@@may@@require@@close@@monitoring@@of@@their@@blood@@glucose@@levels@@and@@adjustment@@of@@the@@dose@@of@@their@@antidiabetic medication@@.@@"> 
      <entity id="DDI-DrugBank.d571.s4.e0" charOffset="17-35" type="group" text="antidiabetic agents" position="3"/>  
      <entity id="DDI-DrugBank.d571.s4.e1" charOffset="47-53" type="brand" text="VELCADE" position="5"/>  
      <entity id="DDI-DrugBank.d571.s4.e2" charOffset="160-182" type="group" text="antidiabetic medication" position="23"/>  
      <pair id="DDI-DrugBank.d571.s4.p0" e1="DDI-DrugBank.d571.s4.e0" e2="DDI-DrugBank.d571.s4.e1" ddi="true" type="advise" flags="True" e1_name="antidiabetic agents" e2_name="VELCADE" e1_pos="3" e2_pos="5" path="3@@4@@6@@5@@">antidiabetic agents@@@@partmod@@receiving@@dobj@@treatment@@amod@@VELCADE</pair>  
      <pair id="DDI-DrugBank.d571.s4.p1" e1="DDI-DrugBank.d571.s4.e0" e2="DDI-DrugBank.d571.s4.e2" ddi="false" flags="True" e1_name="antidiabetic agents" e2_name="antidiabetic medication" e1_pos="3" e2_pos="23" path="3@@0@@8@@17@@20@@23@@">antidiabetic agents@@@@prep_on@@Patients@@nsubj@@require@@dobj@@adjustment@@prep_of@@dose@@prep_of@@antidiabetic medication</pair>  
      <pair id="DDI-DrugBank.d571.s4.p2" e1="DDI-DrugBank.d571.s4.e1" e2="DDI-DrugBank.d571.s4.e2" ddi="false" flags="True" e1_name="VELCADE" e2_name="antidiabetic medication" e1_pos="5" e2_pos="23" path="5@@6@@4@@3@@0@@8@@17@@20@@23@@">VELCADE@@@@amod@@treatment@@dobj@@receiving@@partmod@@antidiabetic agents@@prep_on@@Patients@@nsubj@@require@@dobj@@adjustment@@prep_of@@dose@@prep_of@@antidiabetic medication</pair> 
   </sentence>  
   <sentence id="DDI-DrugBank.d571.s5" text="Drug Laboratory Test Interactions None known." new_text="Drug@@Laboratory@@Test@@Interactions@@None@@known@@.@@"/> 
</document>
